Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
de la Piedra, C, Alcaraz, A, Bellmunt, J, Meseguer, C, Gómez-Caamano, A, Ribal, M J, Vázquez, F, Anido, U, Samper, P, Esteban, E, Álvarez-Ossorio, J L, Lara, P C, San José, L A, Contreras, J A, del Alba, A G, González-Gragera, B, Tabernero, A J, González-Enguita, C, Fernández, J M, García-Escudero, A, Gómez-Veiga, F, Méndez, M J, Segarra, J, Virizuela, J A, Carles, J, Lassa, A, Calderero, V, Constela, M, Delgado, D, Mañas, A, Murias, A, Reynes, G, Rodriguez, B, Rubio, G, Sánchez, E, Unda, M, Solsona, E, Martínez-Javaloyas, J M, Comet-Batlle, J, Quicios, C, Martín-Fernández, M, Mahillo-Fernández, I, Morote, J
Published in British journal of cancer (25.06.2013)
Published in British journal of cancer (25.06.2013)
Get full text
Journal Article
Cognitive function in patients on androgen suppression: A prospective, multicentric study
Morote, J., Tabernero, Á.J., Álvarez-Ossorio, J.L., Ciria, J.P., Domínguez-Escrig, J.L., Vázquez, F., Angulo, J., López, F.J., de La Iglesia, R., Romero, J.
Published in Actas urológicas españolas (English ed.) (01.03.2018)
Published in Actas urológicas españolas (English ed.) (01.03.2018)
Get full text
Journal Article